Skip to main content
letter
. 2024 Sep 28;14(10):2669–2691. doi: 10.1007/s13555-024-01278-x
Patients with atopic dermatitis (AD) in Asia may have a different clinical presentation compared with individuals with non-Asian populations.
To address the unique challenges of managing patients with moderate-to-severe AD in Asia, current landscape and management of AD in the nine territories across Asia were reviewed and discussed.
When managing moderate-to-severe AD, phototherapy should be attempted after failure with topical treatments, followed by conventional disease-modifying antirheumatic drugs and subsequently, biologics or Janus kinase inhibitors. Systemic corticosteroids can be used as short-term therapy for acute flares.